PhRMA’s Contributions to The Fight Against Chronic Diseases

04.09.13 | By

According to the Kaiser Family Foundation, health care expenditures in the United States approached $2.6 trillion in 2010, over ten times the $256 billion spent in 1980.

The expectation this year: Americans will spend $2.9 trillion on health care.  And federal, state and local government agencies are in overdrive to find the best ways to reduce costs and still maintain quality patient care.

Rallying for Medical Research and Progress

04.09.13 | By

8 Years of PPA

04.09.13 | By

Recently the Partnership for Prescription Assistance (PPA) celebrated its eighth anniversary. The PPA was formed to help Americans obtain the prescription medications they need. Since its debut in April 2005, PPA has helped nearly 8 million Americans by connecting them to patient assistance programs across the country.

Shooting for Awareness

04.09.13 | By

Most people have heard of the NBA Hall of Famer, Kareem Abdul-Jabbar. But not everyone is as familiar with chronic myeloid leukemia (CML), a once fatal disease, that he was diagnosed with in 2008. Since being diagnosed, Abdul-Jabbar has been a strong advocate for CML patients, encouraging them to understand their treatment milestones and actively talk to their physicians to ensure their disease is properly managed.

PhRMA's Contributions to The Fight Against Chronic Diseases

04.08.13 | By

According to the Kaiser Family Foundation, health care expenditures in the United States approached $2.6 trillion in 2010, over ten times the $256 billion spent in 1980. The expectation this year: Americans will spend $2.9 trillion on health care. And federal, state and local government agencies are in overdrive to find the best ways to reduce costs and still maintain quality patient care. That commitment is shared by (PhRMA) and its member companies.

Direct to Consumer Advertising Principles – Annual Certifications

Code on Interactions With Health Care Professionals

  • The Pharmaceutical Research and Manufacturers of America (PhRMA) represents research-based pharmaceutical and biotechnology companies. Our members develop and market new medicines to enable patients to live longer and healthier lives.

Learn More About Medicines in Development for HIV/AIDS

America’s biopharmaceutical research companies are currently developing 73 innovative medicines and vaccines to help the nearly 1.2 million Americans living with HIV infection today, according to a new report from PhRMA. The medicines in development – all in either clinical trials or under review by the FDA – include 40 antivirals, 25 vaccines, four cell or gene therapies, and four immunomodulators. Examples of potential innovations included in the report include:

Code on Business Ethics

This Week #PhRMA13 Convenes a New Conversation on Research, Progress and Hope

04.08.13 | By

In just a few days, health care industry leaders, biomedical professionals and patients from across the country will convene at #PhRMA13 in San Diego to discuss the future of medicine and share ideas as to how we can all make PhRMA's mission of research, progress and hope an ongoing reality. The panels throughout the meeting will focus on this mission.

Pages

Subscribe to RSS - Opinion